Investing in the ability to claim that a food or drink product has health benefits is a “worthwhile” process, despite costs of over US$10m, according to research.

A study by Business Insights, published today (23 April) claims that, as consumers become more concerned and knowledgeable about their health, many are looking to self-medicate.

As a result, the analysts believe that large food and drink players are focusing on the potential of the nutraceuticals market, triggering an increase in investment and takeovers – a trend the firm believes will continue to accelerate in the next five years.

This comes despite an increase in costs for clinical research needed to substantiate health claims made on both new and existing ingredients.

“The fact that we’re seeing so much growth in the market, despite the increased costs, illustrates the scope of potential,” Business Insights analyst Dr Cheryl Barton said.

Food and drinks manufacturers such as Danone and Nestlé have invested heavily behind bringing novel nutraceutical products to the health and wellness category.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

However, with consumer healthcare divisions of some major healthcare companies also investing in nutraceuticals, most notably McNeil’s Benecol products, competition is high, Business Insight noted.

“Despite the limitations caused by the tightened regulation and cost, there is massive potential for growth. In this rapidly expanding market, companies will need to differentiate themselves with products that offer an immediate health benefit in days rather than months, to keep consumers coming back for more,” Barton said.

Stay informed for just £1! *

Subscribe to Just Drinks for unbiased coverage of the global drinks industry, offering insights into the corporate strategies of beverage manufacturers and brands worldwide.


What’s included in your subscription:
  • Unlimited access to Just Drinks content including daily global news, in-depth analysis, and interviews with C-suite executives
  • Unbeatable coverage of categories from beer, wine and spirits to soft drinks and hot beverages
  • Unrivalled drinks industry comment from leading sector specialists

Ready to stay informed? Subscribe now and gain access to exclusive content.

Subscribe

Have a subscription? Sign in

For further details on subscribing, click here. Need multi-user access? Explore our corporate subscriptions now.

*After your 1-month trial, your subscription will continue at £315 per year.